Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Trial Profile

Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Dapivirine (Primary) ; Maraviroc (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 06 Mar 2014 Results presented at the 21st Conference on Retroviruses and Opportunistic Infections.
    • 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Aug 2012 Planned End Date changed from 1 Apr 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top